T 0454/01 (Anthracycline glycoside solution/PHARMACIA) of 25.11.2005
- European Case Law Identifier
- ECLI:EP:BA:2005:T045401.20051125
- Date of decision
- 25 November 2005
- Case number
- T 0454/01
- Petition for review of
- -
- Application number
- 91102986.6
- IPC class
- A61K 31/71
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
- Applicant name
- PHARMACIA & UPJOHN S.p.A.
- Opponent name
- Hexal Aktiengesellschaft
Durachemie GmbH & Co. KG - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 106 1973European Patent Convention Art 107 1973European Patent Convention Art 108 1973European Patent Convention Art 123(2) 1973European Patent Convention Art 54 1973European Patent Convention Art 87(1) 1973European Patent Convention Art 87(3) 1973European Patent Convention Art 87(4) 1973European Patent Convention R 64 1973
- Keywords
- Main request - priority (no), subsequent application mentioned in the patent for claiming priority is not a first application within the meaning of Article 87(1) EPC; allowability of the disclaimer (no) - anticipation under Article 54(2) EPC to be excluded not accidental.
Auxiliary request - priority (no) - idem
Novelty (no) - anticipation published before the invalidly claimed priority date - Catchword
- -
- Cited cases
- G 0002/98G 0001/03G 0002/03T 0012/81T 0116/84T 0198/84T 0175/86T 0073/88T 0255/91T 0211/93T 0401/94
- Citing cases
- T 1196/08
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.